Literature DB >> 8664242

Is the incidence of registrable age-related macular degeneration increasing?

J Evans1, R Wormald.   

Abstract

AIMS/
BACKGROUND: Age-related macular degeneration (ARMD) is a growing public health problem in Britain; currently its aetiology is unclear. The aim of this study was to test the hypothesis that the age specific incidence of blinding ARMD has increased in Britain in the past 50 years, using data on cause of visual loss in people registered as blind, published every 10 years since 1950.
METHODS: Data were abstracted from published sources for the years 1950, 1960, 1970, and 1980. Data for the standard year, 1990, were provided in a database from the Office of Population Censuses and Surveys. The numbers of new registrations attributed to ARMD per head of population were compared with registrations for cataract, glaucoma, and optic atrophy. Indirect standardisation was used to control for changes in the age structure of the population over time.
RESULTS: After controlling for changes in the age structure of the population, registration rates for all causes, cataract, glaucoma, and optic atrophy have decreased while registrations attributed to ARMD have increased in the order of 30-40%.
CONCLUSIONS: These findings are compatible with the hypothesis that the incidence of ARMD is increasing in Britain. It is difficult to exclude potential sources of bias in these data, however, particularly with respect to classification and coding of cause; more reliable population based data on ARMD in Britain are needed.

Entities:  

Mesh:

Year:  1996        PMID: 8664242      PMCID: PMC505375          DOI: 10.1136/bjo.80.1.9

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Epidemiological function of BD8 certification.

Authors:  J R Evans; R P Wormald
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

2.  Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  I M Heiba; R C Elston; B E Klein; R Klein
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

3.  The long-term effects of visible light on the eye.

Authors:  H R Taylor; S West; B Muñoz; F S Rosenthal; S B Bressler; N M Bressler
Journal:  Arch Ophthalmol       Date:  1992-01

4.  Blindness and partial sight in an elderly population.

Authors:  J M Gibson; J R Lavery; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

  4 in total
  54 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  CNV subtype in first eyes predicts severity of ARM in fellow eyes.

Authors:  S Abugreen; K A Muldrew; M R Stevenson; R VanLeeuwen; P T V M DeJong; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

4.  Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.

Authors:  L Tejeria; R A Harper; P H Artes; C M Dickinson
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

5.  Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population.

Authors:  J T F Lau; V Lee; D Fan; M Lau; J Michon
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  An eye for discovery.

Authors:  Andreas Stahl; Lois E H Smith
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 7.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

8.  The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study.

Authors:  Jie Jin Wang; Robert J Ross; Jingsheng Tuo; George Burlutsky; Ava G Tan; Chi-Chao Chan; Emmanuel J Favaloro; Andrew Williams; Paul Mitchell
Journal:  Ophthalmology       Date:  2007-08-02       Impact factor: 12.079

9.  Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.

Authors:  B C Reeves; R A Harper; W B Russell
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 10.  Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review.

Authors:  A L Takeda; J Colquitt; A J Clegg; J Jones
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.